Skip to main content

Table 6 Comparison of recurrence and death rates in premenopausal patients with breast cancer treated with tamoxifen (TAM) and toremifene (TOR)

From: A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

  TAM (n = 240) TOR (n = 212) P value
Overall survival(%) 97.9 100 0.087
3 years 99.5 100  
5 years 98.4 100  
8 years 95.5 100  
Recurrence-free survival(%) 90.4 97.2 0.022
3 years 94.8 98.8  
5 years 90.7 95.6  
8 years 88.9 89.3  
  1. Differences between the groups were evaluated using log-rank tests for unadjusted analyses.